Compare ARK Genomic Revolution ETF (ARKG) vs US Bancorp (USB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs US Bancorp — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while US Bancorp trades at $62.41 (market cap $97.22B). The key difference: US Bancorp pays a 3.33% dividend while ARK Genomic Revolution ETF pays none, and US Bancorp is trading nearer its 52-week high, ARK Genomic Revolution ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | USB | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $62.89 |
52-Week Low | $23.09 | $43.94 |
Market Cap | — | $97.22B |
Dividend Yield | — | 3.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
U.S. Bancorp (USB) trades at $62.41, up 0.82% with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals with three consecutive quarterly earnings beats, a P/E of 13.08, and net income margin of 27.04%. Recent developments include the launch of Enhanced Payments for small businesses and a planned dividend increase following successful stress test results.
The outlook remains positive with analyst consensus targeting $67.00 (7.4% upside). Key opportunities include sustained earnings growth and dividend reliability, while risks involve negative cash flow trends and rising debt-to-asset ratios. The stock presents a balanced risk-reward profile for value-oriented investors seeking financial sector exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
